Drug Information

Drug General Information
Drug ID
D04CXX
Former ID
DNCL002120
Drug Name
GNKG-168
Indication Chronic lymphocytic leukaemia [ICD10:C91] Phase 1 [524153]
Company
SBI Biotech
Target and Pathway
Target(s) Toll-like receptor 9 Target Info Modulator [550450]
KEGG Pathway Toll-like receptor signaling pathway
Chagas disease (American trypanosomiasis)
African trypanosomiasis
Malaria
Tuberculosis
Measles
Herpes simplex infection
NetPath Pathway BCR Signaling Pathway
PANTHER Pathway Toll receptor signaling pathway
Reactome PI3K Cascade
Trafficking and processing of endosomal TLR
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
MyD88 dependent cascade initiated on endosome
WikiPathways Toll-like receptor signaling pathway
Toll-Like Receptors Cascades
MyD88 dependent cascade initiated on endosome
Trafficking and processing of endosomal TLR
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
Regulation of toll-like receptor signaling pathway
References
Ref 524153ClinicalTrials.gov (NCT01743807) Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia. U.S. National Institutes of Health.
Ref 550450National Cancer Institute Drug Dictionary (drug id 662816).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.